[Betalactam resistant Streptococcus pneumoniae and management of pneumococcal meningitis]

Enferm Infecc Microbiol Clin. 2003 Jan;21(1):3-6. doi: 10.1016/s0213-005x(03)72867-5.
[Article in Spanish]
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use
  • Cefotaxime / therapeutic use
  • Dexamethasone / therapeutic use
  • Drug Resistance, Bacterial
  • Humans
  • Meningitis, Haemophilus / drug therapy
  • Meningitis, Pneumococcal / drug therapy*
  • Metalloproteins / therapeutic use
  • Neisseria meningitidis / drug effects
  • Spain
  • Streptococcus pneumoniae / drug effects*
  • Vaccines, Conjugate / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Metalloproteins
  • Vaccines, Conjugate
  • Dexamethasone
  • Cefotaxime